GIP promotes the proper storage of lipids in adipose tissue, whereas the robust fat oxidation mechanism of GLP-1 increases the utilization of these deposited lipids
Formal switching protocols arent tested in late trials yet, for the simple reason that retatrutide isnt approved
Patient counseling should include: Realistic expectations about generalized rather than targeted fat loss The importance of combining medication with lifestyle modifications Recognition that individual response varies based on genetics, baseline body composition, and adherence Understanding that sustainable results require long-term commitment For optimal outcomes, GLP-1 therapy should be integrated into a comprehensive weight management program that includes nutritional counseling, regular physical activity (particularly resistance training to preserve lean muscle mass), behavioral therapy, and ongoing medical supervision
Similarly, body weight was reduced by 5.2 percent to 5.7 percent with ecnoglutide after 52 weeks, while it was reduced by 3.9 percent to 5.7 percent with semaglutide after 30 weeks
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
Can I add more water after initial reconstitution